HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Most Shorted Stocks

1,038.296

+0.3580.03%

Number of Gainers:13

Number of Losers:8

Number of Flat:7

PE:- -

High:1,044.111

Open:1,037.899

Low:1,020.658

Close:1,037.938

Loading ...

BREAKINGVIEWS-CK Hutchison deal is test of Chinese hospitality: podcast

BRIEF-Beigene Says Pharmacyclics Litigation Is Not Expected To Affect Operation

Beigene Says Pharmacyclics Litigation Is Not Having Adverse Effect on Development, Sales of Brukinsa in U.S.

THOMSON REUTERS

Samsonite International SA Reports $237.4 Million Net Income for 2024; Significant Turnaround from Previous Year's Loss

BRIEF-Tianli International Posts H1 Gross Profit RMB705.1 Million

Tianli International Holdings H1 Gross Margin 37.6%

THOMSON REUTERS

Tianli Education International - Hy Revenue RMB1.88 Bln

THOMSON REUTERS

Shares of CK Hutchison up 2%

THOMSON REUTERS

China Regulators Say CK Hutchison Port Deals Should Not Evade Antitrust Reviews

MT Newswires Live

Sinopharm's Q1 Profit Jumps

MT Newswires Live

BUZZ-China's Sinopharm rises most in over six months as quarterly profit climbs

Sinopharm Group Q1 Net Income RMB 1,457 Million

THOMSON REUTERS

China says parties to CK Hutchison's ports deal must not avoid antitrust review

China's Top Market Regulator, on Media Report of Separating Panama Ports From Hutchison Deal: We Are Paying Close Attention to the Transaction, Will Review Them in Accordance With the Law

THOMSON REUTERS

China's Top Market Regulator: Parties to the Transaction Must Not Use Any Means to Avoid Review

THOMSON REUTERS

China New Higher Education Group Announces FY2024/25 Interim Results Advancing Steadily for High-Quality Development, Continuing to Provide Education That Satisfies the People

THOMSON REUTERS

BRIEF-China New Higher Education Group Posts H1 Gross Profit RMB 544.2 Million

China New Higher Education Group H1 Gross Margin 38.5%

THOMSON REUTERS

BRIEF-Sinopharm Group Posts Qtrly Net Profit Attributable RMB328 Million For Sinopharm Accord

Rpt-Sinopharm Group - Qtrly Net Profit Attributable RMB328 Mln for Sinopharm Accord

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1500/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1500","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1500\",,,,,undefined,":{"symbol":"BK1500","market":"HK","secType":"PLATE","nameCN":"Most Shorted Stocks","latestPrice":1038.296,"timestamp":1746173303349,"preClose":1037.9381,"halted":0,"volume":129971343,"delay":0,"changeRate":0.000345,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed The Birthday of the Buddha","change":0.35791,"latestTime":"05-02 16:00:00","open":1037.8989,"high":1044.111,"low":1020.65845,"amount":2034118146,"amplitude":0.022595,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746495000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1746149400000,1746158400000],[1746162000000,1746172800000]],"pbRate":1.031994,"peRate":14.047188,"turnoverRate":0.001119,"increases":14,"decrements":9,"flats":4,"marketCap":1182772019636,"floatMarketCap":1133197861300},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1500\",,,,,undefined,":{"symbol":"BK1500","high":1044.111,"amplitude":0.022595,"preClose":1037.9381,"low":1020.65845,"pbRate":"1.031994","latestPrice":1038.296,"volume":129971343,"delay":0,"open":1037.8989,"prevYearClose":930.77496,"prevWeekClose":1038.296,"prevMonthClose":1037.938,"prevQuarterClose":1067.049,"fiveDayClose":1020.157,"twentyDayClose":1067.049,"sixtyDayClose":962.906,"secType":"PLATE","market":"HK","turnoverRate":0.001119,"peRate":14.047188,"marketCap":1182772019636,"floatMarketCap":1133197861300,"timestamp":1746173303349,"nameCN":"Most Shorted Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1500\",,,,undefined,":{"bkCode":"BK1500","up":13,"down":8,"flat":7},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1500\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532704419","title":"BREAKINGVIEWS-CK Hutchison deal is test of Chinese hospitality: podcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2532704419","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532704419?lang=en_us&edition=fundamental","pubTime":"2025-05-01 13:36","pubTimestamp":1746077801,"startTime":"0","endTime":"0","summary":"BREAKINGVIEWS-CK Hutchison deal is test of Chinese hospitality: podcastThe hosts are Reuters Breakingviews columnists.  The opinions expressed are their own.  Refiles to remove extraneous link.By Aimee  Donnellan, Una Galani. LONDON/HONG KONG, May 1  - Follow on Appleor Spotify. Listen on the Reuters app. Read the episode transcript.The Li clan is facing political hurdles as it tries to offload the docks business to BlackRock for $23 billion. In this Viewsroom podcast, Breakingviews columnists explain why China objects, and why it might create bigger problems for inward investment.Follow @aimeedonnellan and @ugalani on XFURTHER READING. BlackRock gets bargain berth in Panama trade storm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nL8N3R82MZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4534","BK4135","BK4585","IE00B64PRP62.GBP","BK1569","00001","IE0032431581.USD","LU2430703178.SGD","IE00B3QW5Z07.USD","IE00B3PB1722.GBP","BK1230","IE00BVYPNV92.GBP","LU1670627923.USD","LU0130102774.USD","LU0980610538.SGD","BK4588","LU0640476718.USD","LU1201861249.SGD","LU1291159041.SGD","LU1989771016.USD","BK4504","IE00B42XCP33.USD","LU0072462343.USD","LU2592432038.USD","LU0772969993.USD","LU2430703095.HKD","LU1064131342.USD","LU1280957306.USD","BK1601","LU1599440770.SGD","LU0731783394.SGD","BK1500","LU0070302665.USD","LU2264538146.SGD","IE00BDGV0183.EUR","LU2430703251.USD","BK4567","IE00BGHQF631.EUR","LU0648001328.SGD","IE00BVYPNW00.USD","BLK","LU1481011911.USD","IE00BGHQF748.EUR","LU0731783048.USD","LU1509826696.USD","LU0320765489.SGD","BK4581","LU1481011671.HKD","LU0208291251.USD"],"gpt_icon":0},{"id":"2531743631","title":"BRIEF-Beigene Says Pharmacyclics Litigation Is Not Expected To Affect Operation","url":"https://stock-news.laohu8.com/highlight/detail?id=2531743631","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531743631?lang=en_us&edition=fundamental","pubTime":"2025-04-30 08:19","pubTimestamp":1745972342,"startTime":"0","endTime":"0","summary":"BRIEF-Beigene Says Pharmacyclics Litigation Is Not Expected To Affect OperationApril 30  - Beigene 688235.SS:SAYS PHARMACYCLICS LITIGATION IS NOT HAVING ADVERSE EFFECT ON DEVELOPMENT, SALES OF BRUKINSA IN U.S.SAYS PHARMACYCLICS LITIGATION IS NOT EXPECTED TO HAVE companyADVERSE EFFECT ON CO'S PRODUCTION, OPERATIONSource textFurther company coverage: 688235.SS  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nL4N3R801B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","BK1588","LU0588546209.SGD","688235","BK1583","LU0307460666.USD","BK0239","LU2328871848.SGD","BK1161","LU1969619763.USD","06160"],"gpt_icon":0},{"id":"2531487697","title":"Beigene  Says Pharmacyclics Litigation Is Not Having Adverse Effect on Development, Sales of Brukinsa in U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2531487697","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531487697?lang=en_us&edition=fundamental","pubTime":"2025-04-30 08:19","pubTimestamp":1745972341,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nL4N3R801B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0307460666.USD","BK1500","BK0239","BK1161","BK1588","LU0588546209.SGD","LU2328871848.SGD","BK1583","LU1969619763.USD","06160","688235"],"gpt_icon":0},{"id":"2531482237","title":"Samsonite International SA Reports $237.4 Million Net Income for 2024; Significant Turnaround from Previous Year's Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2531482237","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531482237?lang=en_us&edition=fundamental","pubTime":"2025-04-30 07:09","pubTimestamp":1745968174,"startTime":"0","endTime":"0","summary":"Samsonite International S.A. reported its financial results for the year ending December 31, 2024. The company achieved a net profit of $237.4 million, a significant turnaround from the previous year's net loss of $1.9 million. A notable business update includes the repurchase of 62.6 million shares, representing 4.3% of the issued share capital, which resulted in a total cash outflow of $157.6 million. Samsonite did not engage in any research and development activities during the financial year. The company continues to hold its investment in Samsonite Sub Holdings S.à r.l. at a net book value of approximately $1.945 billion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Samsonite International SA published the original content used ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nNDL3cvPtz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0607220059.USD","SG9999011746.SGD","LU1880383366.USD","BK1500","LU0149534421.HKD","LU2065169927.USD","01910","LU2065170008.USD","SG9999004303.SGD","SGXZ23171101.USD","LU0572940350.SGD","BK1602","LU2065171311.SGD","LU0264606111.USD","LU2065171402.SGD","LU0823040885.USD","BK1227","LU0251143458.SGD","LU0572939691.SGD","BK1577","SG9999004311.SGD"],"gpt_icon":0},{"id":"2531752617","title":"BRIEF-Tianli International Posts H1 Gross Profit RMB705.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2531752617","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531752617?lang=en_us&edition=fundamental","pubTime":"2025-04-29 23:16","pubTimestamp":1745939781,"startTime":"0","endTime":"0","summary":"BRIEF-Tianli International Posts H1 Gross Profit RMB705.1 MillionApril 29 (Reuters) - Tianli International Holdings Ltd 1773.HK:H1 GROSS PROFIT RMB 705.1 MILLIONH1 GROSS MARGIN 37.6%Further company coverage: 1773.HK ((Reuters.Briefs@thomsonreuters.com))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nPLXF48475:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1596","BK1556","BK1228","01773","BK1500"],"gpt_icon":0},{"id":"2531735944","title":"Tianli International Holdings H1 Gross Margin 37.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531735944","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531735944?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:37","pubTimestamp":1745930222,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nPLXF48475:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01773","BK1596","BK1556","BK1500","BK1228"],"gpt_icon":0},{"id":"2531735661","title":"Tianli Education International -  Hy Revenue RMB1.88 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2531735661","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531735661?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:34","pubTimestamp":1745930059,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nFWN3R720D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1596","01773","BK1556","BK1228","BK1500"],"gpt_icon":0},{"id":"2531805215","title":"Shares of CK Hutchison  up 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531805215","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531805215?lang=en_us&edition=fundamental","pubTime":"2025-04-29 09:33","pubTimestamp":1745890403,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4N3R7035:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1500","IE0032431581.USD","00001","LU0072462343.USD","BK1601","LU1048588211.SGD","BK1230","LU1571399168.USD","BK1521","BK1569"],"gpt_icon":0},{"id":"2530424929","title":"China Regulators Say CK Hutchison Port Deals Should Not Evade Antitrust Reviews","url":"https://stock-news.laohu8.com/highlight/detail?id=2530424929","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530424929?lang=en_us&edition=fundamental","pubTime":"2025-04-28 17:26","pubTimestamp":1745832369,"startTime":"0","endTime":"0","summary":"China's State Administration for Market Regulation said CK Hutchison's  planned sale of most of its ports to a BlackRock-led consortium should not avoid antitrust reviews, the regulator said Sunday.\"The parties to the transaction shall not circumvent the review in any way and shall not implement the concentration before approval, otherwise they will bear legal responsibility,\" the regulator said.Beijing made the comment after the Wall Street Journal said BlackRock's MSC shipping empire held discussions regarding moving forward with the deal while disputes regarding the ports near the Panama Canal are resolved, Reuters reported separately.CK Hutchison's deals have two different structures: one for the Panama ports and another for all other ports, Reuters said.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1509826696.USD","BK4534","LU1280957306.USD","LU0208291251.USD","00001","BK4581","LU0070302665.USD","LU1571399168.USD","BK4585","LU0731783048.USD","LU0731783394.SGD","LU1670628061.USD","LU0320765489.SGD","LU1481011911.USD","LU2430703178.SGD","BK1521","IE00BGHQF748.EUR","LU2505996681.GBP","LU0648001328.SGD","BK4533","LU0772969993.USD","BK4504","LU1599440770.SGD","IE00B3PB1722.GBP","LU1988902786.USD","IE00B3QW5Z07.USD","LU1201861249.SGD","BLK","LU2430703095.HKD","IE00BVYPNW00.USD","IE00B64PRP62.GBP","IE00BVYPNV92.GBP","BK1569","LU1481011671.HKD","IE0032431581.USD","LU2592432038.USD","LU2505996509.AUD","LU1291159041.SGD","BK4535","LU1048588211.SGD","BK4567","BK1500","BK4588","LU0072462343.USD","LU0742537680.HKD","LU0130102774.USD","LU1074936037.SGD","LU0980610538.SGD","BK4135","IE00BDGV0183.EUR"],"gpt_icon":0},{"id":"2530429398","title":"Sinopharm's Q1 Profit Jumps","url":"https://stock-news.laohu8.com/highlight/detail?id=2530429398","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530429398?lang=en_us&edition=fundamental","pubTime":"2025-04-28 17:03","pubTimestamp":1745831013,"startTime":"0","endTime":"0","summary":"Sinopharm's  attributable profit rose to 1.46 billion yuan in the first quarter from 1.42 billion yuan in the year-ago period, according to a Monday filing with the Hong Kong bourse.Earnings per share at the drug company increased to 0.47 yuan from 0.46 yuan in the previous year.Operating revenue declined to 141.7 billion yuan from 147.3 billion yuan in the prior-year period.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1197","BK1500","01099","LU1115378108.SGD","BK1515","LU0640798160.USD"],"gpt_icon":0},{"id":"2530443728","title":"BUZZ-China's Sinopharm rises most in over six months as quarterly profit climbs","url":"https://stock-news.laohu8.com/highlight/detail?id=2530443728","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530443728?lang=en_us&edition=fundamental","pubTime":"2025-04-28 14:37","pubTimestamp":1745822255,"startTime":"0","endTime":"0","summary":"BUZZ-China's Sinopharm rises most in over six months as quarterly profit climbs** Shares of Sinopharm Group 1099.HK rise 4.1% to HK$18.14, the biggest intraday pct gain since October 7 ** Stock hits the highest point since April 23, snapping three straight session of losses, and is top pct gainer in the Hang Seng Index .HSI, which climbs 0.2%** The Chinese pharmaceutical, healthcare products and medical devices distributor said its first-quarter net profit up 2.6% y/y at 1.46 billion yuan  while revenue down 3.8% y/y at 141.7 billion yuan ** Citi keeps \"buy\" rating given Sinopharm's earnings growth potential from expectations of industry consolidation down the road, likely market share gain due to network expansion and less concern on finance costs** Hang Seng Commerce & Industry Index .HSNC slips 0.2%,  healthcare index .HSCIH falls 1.5%** Stock down 14.9% YTD    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nL1N3R606S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU0072461881.USD","LU0130102774.USD","LU0648001328.SGD","LU0162691827.USD","LU1668664300.SGD","LU2125154935.USD","LU0130517989.USD","LU0980610538.SGD","BK4504","LU0320765646.SGD","LU0128525689.USD","LU2360032135.SGD","BK4588","BK4585","BK4559","BK1500","BK1197","IE00BSNM7G36.USD","LU0170899867.USD","LU1791807156.HKD","LU0310800965.SGD","LU1267930227.SGD","LU2417539215.USD","LU2125154778.USD","LU0098860793.USD","LU1115378108.SGD","LU1162221912.USD","LU2456880835.USD","BK1515","LU0106831901.USD","BK4534","LU1201861249.SGD","LU2462157665.USD","01099","LU1366192091.USD","LU0052756011.USD","LU0477156953.USD","BK4207","LU2236285917.USD","LU0640798160.USD"],"gpt_icon":0},{"id":"2530697234","title":"Sinopharm Group Q1 Net Income RMB 1,457 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2530697234","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530697234?lang=en_us&edition=fundamental","pubTime":"2025-04-28 06:57","pubTimestamp":1745794667,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250427:nPLXB2A6A2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1115378108.SGD","BK1515","LU0640798160.USD","01099","BK1500","BK1197"],"gpt_icon":0},{"id":"2530343806","title":"China says parties to CK Hutchison's ports deal must not avoid antitrust review","url":"https://stock-news.laohu8.com/highlight/detail?id=2530343806","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530343806?lang=en_us&edition=fundamental","pubTime":"2025-04-27 17:11","pubTimestamp":1745745067,"startTime":"0","endTime":"0","summary":"BEIJING, April 27  - China's top market regulator said on Sunday that parties to CK Hutchison's ports deal must not use any means to avoid an antitrust review, according to an official statement. \"No concentration of undertakings shall be implemented without approval, otherwise legal liability will be incurred,\" the State Administration for Market Regulation said in a statement, in response to a media report of separating Panama ports from a Hutchison deal.  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250427:nP8N3KV0IS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00001","BK1601","IE0032431581.USD","BK1500","LU1571399168.USD","BK1230","LU1048588211.SGD","LU0072462343.USD","BK1569","BK1521"],"gpt_icon":0},{"id":"2530480267","title":"China's Top Market Regulator, on Media Report of Separating Panama Ports From Hutchison Deal: We Are Paying Close Attention to the Transaction, Will Review Them in Accordance With the Law","url":"https://stock-news.laohu8.com/highlight/detail?id=2530480267","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530480267?lang=en_us&edition=fundamental","pubTime":"2025-04-27 17:09","pubTimestamp":1745744992,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250427:nP8N3KV0IS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1521","BK1230","LU1048588211.SGD","BK1601","00001","IE0032431581.USD","LU1571399168.USD","BK1500","LU0072462343.USD","BK1569"],"gpt_icon":0},{"id":"2530480260","title":"China's Top Market Regulator: Parties to the Transaction Must Not Use Any Means to Avoid Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2530480260","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530480260?lang=en_us&edition=fundamental","pubTime":"2025-04-27 17:09","pubTimestamp":1745744992,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250427:nP8N3KV0IS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1500","00001","BK1521","LU0072462343.USD","BK1569","BK1601","IE0032431581.USD","LU1571399168.USD","BK1230","LU1048588211.SGD"],"gpt_icon":0},{"id":"2530948317","title":"China New Higher Education Group Announces FY2024/25 Interim Results Advancing Steadily for High-Quality Development,  Continuing to Provide Education That Satisfies the People","url":"https://stock-news.laohu8.com/highlight/detail?id=2530948317","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530948317?lang=en_us&edition=fundamental","pubTime":"2025-04-25 10:00","pubTimestamp":1745546448,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nTUC87JNXW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1595","02001","BK1500","BK1228"],"gpt_icon":0},{"id":"2529953905","title":"BRIEF-China New Higher Education Group Posts H1 Gross Profit RMB 544.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2529953905","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529953905?lang=en_us&edition=fundamental","pubTime":"2025-04-24 23:17","pubTimestamp":1745507876,"startTime":"0","endTime":"0","summary":"BRIEF-China New Higher Education Group Posts H1 Gross Profit RMB 544.2 MillionApril 24  - China New Higher Education Group Ltd 2001.HK:H1 GROSS PROFIT RMB 544.2 MILLIONH1 GROSS MARGIN 38.5%H1 CAPEX RMB 393.3 MILLIONHY NET PROFIT RMB469.3 MILLIONHY TOTAL REVENUE RMB1,651.3 MILLIONFurther company coverage: 2001.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nPLXA39B99:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02001","BK1500","BK1595","BK1228"],"gpt_icon":0},{"id":"2529875359","title":"China New Higher Education Group H1 Gross Margin 38.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529875359","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529875359?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:56","pubTimestamp":1745499382,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nPLXA39B99:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1228","BK1500","BK1595","02001"],"gpt_icon":0},{"id":"2529608701","title":"BRIEF-Sinopharm Group Posts Qtrly Net Profit Attributable RMB328 Million For Sinopharm Accord","url":"https://stock-news.laohu8.com/highlight/detail?id=2529608701","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529608701?lang=en_us&edition=fundamental","pubTime":"2025-04-24 17:54","pubTimestamp":1745488471,"startTime":"0","endTime":"0","summary":"BRIEF-Sinopharm Group Posts Qtrly Net Profit Attributable RMB328 Million For Sinopharm AccordApril 24  - Sinopharm Group Co Ltd 1099.HK:Q1 REVENUE RMB 18,294 MILLION FOR SINOPHARM ACCORDQTRLY NET PROFIT ATTRIBUTABLE RMB328 MILLION FOR SINOPHARM ACCORDFurther company coverage: 1099.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nL8N3R20VD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","BK0188","BK0185","01099","LU1115378108.SGD","BK1500","BK0250","BK0028","LU0640798160.USD","BK0196","BK0010","BK0082","BK0175","BK1515","000028"],"gpt_icon":0},{"id":"2529267029","title":"Rpt-Sinopharm Group - Qtrly Net Profit Attributable RMB328 Mln for Sinopharm Accord","url":"https://stock-news.laohu8.com/highlight/detail?id=2529267029","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529267029?lang=en_us&edition=fundamental","pubTime":"2025-04-24 17:54","pubTimestamp":1745488471,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nL8N3R20VD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1197","BK0188","BK0185","01099","LU1115378108.SGD","BK1500","BK0250","BK0028","LU0640798160.USD","BK0196","BK0010","BK0082","BK0175","BK1515","000028"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":30,"code":"91000000","status":"200"}]}}